Thromboxane b2

Thromboxane b2 is a lipid of Fatty Acyls (FA) class. Thromboxane b2 is associated with abnormalities such as endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia and Thrombocytosis. The involved functions are known as Platelet Activation, Excretory function, Anabolism, Inflammation and mRNA Expression. Thromboxane b2 often locates in Endothelium, Hepatic and Microsomes, Liver. The associated genes with Thromboxane b2 are PTGS2 gene, prothrombin fragment 2 and CCL14 wt Allele.

Cross Reference

Introduction

To understand associated biological information of Thromboxane b2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Thromboxane b2?

Thromboxane b2 is suspected in endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia, Thrombocytosis, Acute Coronary Syndrome and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Thromboxane b2

MeSH term MeSH ID Detail
Acute Coronary Syndrome D054058 11 associated lipids
Airway Remodeling D056151 3 associated lipids
Acute Kidney Injury D058186 34 associated lipids
Per page 10 20 50 100 | Total 293

PubChem Associated disorders and diseases

What pathways are associated with Thromboxane b2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Thromboxane b2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Thromboxane b2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Thromboxane b2?

There are no associated biomedical information in the current reference collection.

What genes are associated with Thromboxane b2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Thromboxane b2?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Thromboxane b2

Download all related citations
Per page 10 20 50 100 | Total 6367
Authors Title Published Journal PubMed Link
Halushka PV et al. Insulin and arachidonic acid metabolism in diabetes mellitus. 1985 Metab. Clin. Exp. pmid:3934501
Kimura Y et al. Effects of stilbenes on arachidonate metabolism in leukocytes. 1985 Biochim. Biophys. Acta pmid:3922423
Packham MA et al. Duration of the effect of aspirin on the synthesis of thromboxane by density subpopulations of rabbit platelets stimulated with thrombin. 1985 Blood pmid:3926022
Cattaneo M et al. Human platelet aggregation and release reaction induced by platelet activating factor (PAF-acether)--effects of acetylsalicylic acid and external ionized calcium. 1985 Thromb. Haemost. pmid:3927505
Aitokallio-Tallberg A et al. Prostacyclin and thromboxane in breast cancer: relationship between steroid receptor status and medroxyprogesterone acetate. 1985 Br. J. Cancer pmid:2986666
Callahan KS et al. Enhancement of the antiaggregatory activity of prostacyclin by propranolol in human platelets. 1985 Circulation pmid:2986877
Schmitz JM et al. Vascular prostaglandin and thromboxane production in a canine model of myocardial ischemia. 1985 Circ. Res. pmid:3926340
Apprill P et al. Cyclic blood flow variations induced by platelet-activating factor in stenosed canine coronary arteries despite inhibition of thromboxane synthetase, serotonin receptors, and alpha-adrenergic receptors. 1985 Circulation pmid:2988822
Friedrich T et al. Follow-up of prostaglandin plasma levels after acute myocardial infarction. 1985 Am. Heart J. pmid:3880994
Wilson TW and Tan LK Low plasma renin activity in diabetes. Relation to urine prostaglandin excretion. 1985 Diabetes pmid:3881302
Longenecker GL et al. Kinetics of ibuprofen effect on platelet and endothelial prostanoid release. 1985 Clin. Pharmacol. Ther. pmid:3882308
de Lorgeril M et al. Acute influence of cigarette smoke in platelets, catecholamines and neurophysins in the normal conditions of daily life. 1985 Eur. Heart J. pmid:2937635
Lelcuk S et al. Prostacyclin and thromboxane A2 moderate postischemic renal failure. 1985 Surgery pmid:3895535
Paajanen H and Kormano M Prostacyclin (PGI2) and thromboxane (TXA2) levels during intravenous contrast medium administration in CT. 1985 Eur J Radiol pmid:3896802
Yui Y et al. A new stable prostacyclin analogue OP41483 (15-cyclopentyl-omega-pentanor-5(E)-carbacyclin). 1985 Jpn. Circ. J. pmid:3897597
Codde JP and Beilin LJ Dietary fish oil prevents dexamethasone induced hypertension in the rat. 1985 Clin. Sci. pmid:3905217
Martin JL et al. Effect of high dose aspirin on coronary hemodynamics during pacing-induced myocardial ischemia. 1985 J. Am. Coll. Cardiol. pmid:3968305
De Caterina R et al. Inhibition of platelet aggregation and thromboxane B2 production during aspirin treatment: dependence on the dose of the aggregating agent. 1985 Thromb. Res. pmid:3975876
Cook JA et al. Exchange transfusions in rats with a perfluorated blood substitute: effect on thromboxane B2 levels during endotoxemia. 1985 Circ. Shock pmid:3978769
Schrör K et al. [Inhibition of platelet aggregation and thromboxane formation by the calcium antagonist nisoldipine following a single oral dose of 10 mg. A double-blind study in healthy probands]. 1985 Klin. Wochenschr. pmid:3838352
Bult H et al. Modification of endotoxin-induced haemodynamic and haematological changes in the rabbit by methylprednisolone, F(ab')2 fragments and rosmarinic acid. 1985 Br. J. Pharmacol. pmid:3838489
Tada M et al. Augmented thromboxane A2 generation and efficacy of its blockade in acute myocardial infarction. 1985 Int. J. Cardiol. pmid:4040500
Wargovich T et al. Reduction in blood flow in normal and narrowed coronary arteries of dogs by leukotriene C4. 1985 J. Am. Coll. Cardiol. pmid:4045029
Elliott GR et al. Arachidonic acid, an in vivo inhibitor of carrageenin induced granulomas in the rat. 1985 Eur. J. Pharmacol. pmid:2988985
Feuerstein G et al. Effects of nafazatrom on cardiovascular, sympathetic, and endocrine responses to hemorrhagic shock in conscious rats. 1985 Circ. Shock pmid:3841032
Cerletti C et al. Aspirin kinetics and inhibition of platelet thromboxane generation-relevance for a solution of the "aspirin dilemma". 1985 Thromb. Haemost. pmid:4049312
Dejana E et al. Differential salicylate-aspirin interaction on vascular prostacyclin and platelet thromboxane synthesis in patients undergoing saphenectomy. 1985 Proc. Soc. Exp. Biol. Med. pmid:3841210
Fiedler VB et al. The effects of nafazatrom in an acute occlusion-reperfusion model of canine myocardial injury. 1985 Naunyn Schmiedebergs Arch. Pharmacol. pmid:3841382
Palmer RM and Salmon JA Comparison of the effects of some compounds on human neutrophil degranulation and leukotriene B4 and thromboxane B2 synthesis. 1985 Biochem. Pharmacol. pmid:2986647
Fisher M et al. Selective thromboxane inhibition: a new approach to antiplatelet therapy. 1984 Sep-Oct Stroke pmid:6474531
Uderman HD et al. Thromboxane synthetase inhibitor UK38,485 lowers blood pressure in the adult spontaneously hypertensive rat. 1984 Sep-Oct J. Cardiovasc. Pharmacol. pmid:6209508
Sturm M et al. The measurement of plasma thromboxane B2 and the effect of smoking. 1984 Nov-Dec Clin. Exp. Pharmacol. Physiol. pmid:6536421
Menitove JE et al. Use of prostacyclin to inhibit activation of platelets during preparation of platelet concentrates. 1984 Nov-Dec Transfusion pmid:6390814
Tanabe M et al. Inhibition of coronary circulatory failure and thromboxane A2 release during coronary occlusion and reperfusion by 2-phenylaminoadenosine (CV-1808) in anesthetized dogs. 1984 May-Jun J. Cardiovasc. Pharmacol. pmid:6202970
Laustiola K et al. Exercise-induced increase in plasma arachidonic acid and thromboxane B2 in healthy men: effect of beta-adrenergic blockade. 1984 May-Jun J. Cardiovasc. Pharmacol. pmid:6202971
Egg D Concentrations of prostaglandins D2, E2, F2 alpha, 6-keto-F1 alpha and thromboxane B2 in synovial fluid from patients with inflammatory joint disorders and osteoarthritis. 1984 Mar-Apr Z Rheumatol pmid:6730731
De Caterina R et al. Thromboxane-B2 generation during ex-vivo platelet aggregation. 1984 Jul-Sep J. Nucl. Med. Allied Sci. pmid:6530623
Buchanan MR and Hirsh J Effect of aspirin and salicylate on platelet-vessel wall interactions in rabbits. 1984 Jul-Aug Arteriosclerosis pmid:6380468
Paajanen H et al. Modification of platelet aggregation and thromboxane synthesis by intravascular contrast media. 1984 Jul-Aug Invest Radiol pmid:6434489
MacNab MW et al. The effects of a new thromboxane synthetase inhibitor, CGS-13080, in man. 1984 Feb-Mar J Clin Pharmacol pmid:6371062
Marks JG et al. Contact urticaria and airway obstruction from carbonless copy paper. 1984 Aug 24-31 JAMA pmid:6235381
Sheehan DV et al. Some biochemical correlates of panic attacks with agoraphobia and their response to a new treatment. 1984 J Clin Psychopharmacol pmid:6142907
Barnett AH et al. Specific thromboxane synthetase inhibition and albumin excretion rate in insulin-dependent diabetes. 1984 Lancet pmid:6145027
Schenkelaars EJ and Bonta IL Beta 2-adrenoceptor agonists reverse the leukotriene C4-induced release response of macrophages. 1984 Eur. J. Pharmacol. pmid:6151905
Giani E et al. Sex differences in platelet thromboxane and arterial prostacyclin production in control and n-6 fatty acid supplemented rats. 1984 Prostaglandins pmid:6441187
Patrignani P et al. Differential effects of dazoxiben, a selective thromboxane-synthase inhibitor, on platelet and renal prostaglandin-endoperoxide metabolism. 1984 J. Pharmacol. Exp. Ther. pmid:6537977
Vesterqvist O and Gréen K Urinary excretion of 2,3-dinor-thromboxane B2 in man under normal conditions, following drugs and during some pathological conditions. 1984 Prostaglandins pmid:6539491
McCluskey ER et al. In vivo inhibition of thromboxane synthetase in infarcted canine myocardium. 1984 Biochem. Biophys. Res. Commun. pmid:6539597
Chan PK and Gentry PA Inhibition of bovine platelet function by T-2 toxin, HT-2 toxin, diacetoxyscirpenol and deoxynivalenol. 1984 Food Chem. Toxicol. pmid:6540739
Moufarrij NA et al. Thromboxane synthetase inhibition in acute focal cerebral ischemia in cats. 1984 J. Neurosurg. pmid:6542131
Hock CE and Lefer AM Beneficial effect of a thromboxane synthetase inhibitor in traumatic shock. 1984 Circ. Shock pmid:6542462
Ito T et al. Selective thromboxane synthetase inhibitor and ischemic heart disease. 1984 Biomed. Biochim. Acta pmid:6542777
Brown CG and Poyser NL Studies on the control of prostaglandin production by the hypothalamus in relation to LH release in the rat. 1984 J. Endocrinol. pmid:6593408
Okazaki K et al. [Measurement of prostaglandins in human bile juice]. 1984 Nihon Shokakibyo Gakkai Zasshi pmid:6549033
Garcia-Szabo RR et al. Comparison of alpha- and gamma-thrombin on lung fluid balance in anesthetized sheep. 1984 J Appl Physiol Respir Environ Exerc Physiol pmid:6549181
Takeda H et al. [Comparison of centrifugal pump (bio pump) with roller pump: clinical study]. 1984 Kyobu Geka pmid:6549344
Chen LS et al. Plasma concentrations of 6-keto-prostaglandin F1 alpha, thromboxane B2 and platelet aggregation in patients with essential hypertension. 1984 Jpn Heart J pmid:6549401
Ishihara Y et al. [Cigarette smoking and lung metabolism--effect of cigarette smoking on blood levels of 6-keto PGF1 alpha, thromboxane B2 and lipoperoxide in healthy volunteers]. 1984 Nihon Kyobu Shikkan Gakkai Zasshi pmid:6549510
Watanabe J et al. Effect of vitamin E on platelet aggregation in diabetes mellitus. 1984 Thromb. Haemost. pmid:6495252
Stahl RA et al. Glomerular prostaglandin formation in two-kidney, one-clip hypertensive rats. 1984 Am. J. Physiol. pmid:6507633
Kääpä P et al. Thromboxane B2 production by fetal and neonatal platelets: effect of idiopathic respiratory distress syndrome and birth asphyxia. 1984 Pediatr. Res. pmid:6472947
Gross S and Worthington-White DA The effects of PGF2 alpha, PGI2, and TxB2 on human CFU-C in healthy and leukemic patients. 1984 Am. J. Hematol. pmid:6372442
D'Angelo A et al. Increased production of platelet thromboxane B2 in non-insulin-dependent diabetes. Relationship to vascular complications. 1984 Eur. J. Clin. Invest. pmid:6428908
Essien EM et al. Blood changes and enhanced thromboxane and 6-keto prostaglandin F1 alpha production in experimental acute Plasmodium bergei infection in hamsters. 1984 Thromb. Haemost. pmid:6388013
Mäkäräinen L and Ylikorkala O Amniotic fluid 6-keto-prostaglandin F1 alpha and thromboxane B2 during labor. 1984 Am. J. Obstet. Gynecol. pmid:6388335
Baughman RP et al. Prostaglandins and thromboxanes in the bronchoalveolar lavage fluid: possible immunoregulation in sarcoidosis. 1984 Am. Rev. Respir. Dis. pmid:6388445
DiSesa VJ et al. Disadvantages of prostacyclin infusion during cardiopulmonary bypass: a double-blind study of 50 patients having coronary revascularization. 1984 Ann. Thorac. Surg. pmid:6388516
Takeda H et al. [Changes of platelet aggregation, serum thromboxane and prostacyclin in lung cancer and pulmonary metastatic patients following operation]. 1984 Kyobu Geka pmid:6389949
Jackson EK et al. Attenuation of noradrenergic neurotransmission by the thromboxane synthetase inhibitor, UK 38,485. 1984 Life Sci. pmid:6330486
Kawai C New horizons in cardiology. 1984 Int. J. Cardiol. pmid:6334040
McGoon MD and Vanhoutte PM Aggregating platelets contract isolated canine pulmonary arteries by releasing 5-hydroxytryptamine. 1984 J. Clin. Invest. pmid:6470141
Huang HC Release of slow reacting substance from the guinea-pig lung by phospholipases A2 of Vipera russelli snake venom. 1984 Toxicon pmid:6206608
Brunner D et al. Thromboxane, prostacyclin, beta-thromboglobin, and diabetes mellitus. 1984 Clin Ther pmid:6206948
Gragnoli G et al. [Effects of ticlopidine on the plasma levels of beta-thromboglobulin and thromboxane B2 in types 1 and 2 diabetics]. 1984 Minerva Med. pmid:6207465
Rachmilewitz D and Karmeli F Effect of nufenoxole on human colonic prostanoid synthesis, Na-K-ATPase and adenylate cyclase activities. 1984 Eur. J. Pharmacol. pmid:6152213
Stock JL and Coderre JA Calcitonin enhances production of prostaglandins by stimulated human monocytes. 1984 Prostaglandins pmid:6087420
Yui Y et al. Intravenous infusion of a selective inhibitor of thromboxane A2 synthetase in man: influence on thromboxane B2 and 6-keto-prostaglandin F1 alpha levels and platelet aggregation. 1984 Circulation pmid:6434196
Jackson CA et al. Near-normal glycaemic control does not correct abnormal platelet reactivity in diabetes mellitus. 1984 Clin. Sci. pmid:6434224
Coker SJ and Parratt JR The effects of nafazatrom on arrhythmias and prostanoid release during coronary artery occlusion and reperfusion in anaesthetized greyhounds. 1984 J. Mol. Cell. Cardiol. pmid:6366241
Stuart MJ et al. Effects of hyperoxia and hypoxia on vascular prostacyclin formation in vitro. 1984 Pediatrics pmid:6435087
Higashihara M et al. Interaction of Solanum tuberosum agglutinin with human platelets. 1984 Biochem. Biophys. Res. Commun. pmid:6732807
Miyazaki H et al. Microdetermination of prostaglandins and thromboxane B2 by capillary gas chromatography and negative ion chemical ionization mass spectrometry. 1984 J. Chromatogr. pmid:6736155
Kelton JG et al. A study of the bioavailability and platelet inhibitory effects of a new enteric-coated acetylsalicylic acid preparation. 1984 Thromb. Res. pmid:6740573
Ylikorkala O et al. Peritoneal fluid prostaglandins in endometriosis, tubal disorders, and unexplained infertility. 1984 Obstet Gynecol pmid:6232475
Morrison AR and Crowley JR Identification of an unusual cyclooxygenase metabolite of arachidonic acid in rabbit renal medulla. 1984 Arch. Biochem. Biophys. pmid:6437329
Foegh ML et al. Monitoring of rat heart allograft rejection by urinary thromboxane. 1984 Transplant. Proc. pmid:6390873
Willerson JT et al. Conversion from chronic to acute coronary artery disease: speculation regarding mechanisms. 1984 Am. J. Cardiol. pmid:6391133
Fareed J et al. Molecular markers of contrast media-induced adverse reactions. 1984 Semin. Thromb. Hemost. pmid:6393351
Takeda H et al. [Alternations in coagulation and fibrinolysis associated with extracorporeal circulation--the role of vasoactive prostanoids]. 1984 Rinsho Kyobu Geka pmid:6395300
Tada M et al. Reduction of prostacyclin synthesis as a possible cause of transient flow reduction in a partially constricted canine coronary artery. 1984 J. Mol. Cell. Cardiol. pmid:6398370
Ylikorkala O Prostanoids in gynaecology. 1984 Ann. Clin. Res. pmid:6398666
Vapaatalo H et al. Prostanoids in blood pressure regulation and their role in the blood pressure lowering effects induced by changes in dietary fats. 1984 Ann. Clin. Res. pmid:6398981
Wang JP et al. XC 386: a new antiplatelet agent. 1984 Thromb. Res. pmid:6438827
Fuller RW et al. Dexamethasone inhibits the production of thromboxane B2 and leukotriene B4 by human alveolar and peritoneal macrophages in culture. 1984 Clin. Sci. pmid:6091982
Gal D et al. Effect of radiation on prostaglandin production by human bowel in vitro. 1984 Int. J. Radiat. Oncol. Biol. Phys. pmid:6588048
Oglesby TD and Gorman RR The inhibition of arachidonic acid metabolism in human platelets by RHC 80267, a diacylglycerol lipase inhibitor. 1984 Biochim. Biophys. Acta pmid:6424715
Eldor A et al. The effect of oral administration of dipyrone on the capacity of blood platelets to synthesize thromboxane A2 in man. 1984 Eur. J. Clin. Pharmacol. pmid:6723755
Cerletti C et al. Plasma levels of salicylate and aspirin in healthy volunteers: relevance to drug interaction on platelet function. 1984 J. Lab. Clin. Med. pmid:6726057
Anderson CB et al. Renal thromboxane synthesis in excised kidney distal to renovascular lesions. 1984 JAMA pmid:6726983
Grignani G et al. Activation of platelet prostaglandin biosynthesis pathway during neoplastic cell-induced platelet aggregation. 1984 Thromb. Res. pmid:6729776